Quest Diagnostics (DGX) Price to Sales (2009 - 2026)

Quest Diagnostics has disclosed Price to Sales across 18 years of filings, most recently posting 7.69 for Q2 2026.

• In Q2 2026, Price to Sales rose 5.67% year-over-year to 7.69; the TTM figure through Jun 2026 stood at 2.02 (up 6.01% YoY), while the FY2025 annual figure was 1.73, up 1.87% from the prior year.
• Price to Sales came in at 7.69 for Q2 2026 at Quest Diagnostics, up from 7.49 in the prior quarter.
• In the past five years, Price to Sales ranged from a high of 7.69 in Q2 2026 to a low of 5.62 in Q3 2022.
• Average Price to Sales over 5 years is 6.76, with a median of 6.77 recorded in 2023.
• Year-over-year, Price to Sales fell 12.53% in 2022 and increased 16.66% in 2024.
• Over 5 years, Price to Sales stood at 7.46 in 2022, then fell by 10.63% to 6.67 in 2023, then decreased by 4.25% to 6.39 in 2024, then climbed by 6.37% to 6.79 in 2025, then increased by 13.15% to 7.69 in 2026.
• Per Business Quant data, the three most recent Price to Sales figures were 7.69 in Q2 2026, 7.49 in Q1 2026, and 6.79 in Q4 2025.